The immune response to tuberculosis infection in the setting of Helicobacter pylori and helminth infections

Epidemiology and Infection

Volumn 141, Issue 6, 2013, Pages 1232-1243

  Perry, S ^a   Chang, A H ^a   Sanchez, L ^a   Yang, S ^a   Haggerty, T D ^a   Parsonnet, J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Helicobacter pylori; helminths; immunology; principal components analysis; tuberculosis infection

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BACTERIAL IMMUNITY; CONCURRENT INFECTION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE RESPONSE; FEMALE; HELICOBACTER INFECTION; HELMINTHIASIS; HUMAN; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; REFUGEE; TH1 CELL; UNITED STATES;

ADOLESCENT; ADULT; COINFECTION; CROSS-SECTIONAL STUDIES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HELMINTHIASIS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-13; INTERLEUKIN-2; INTERLEUKIN-5; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84876914790     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268812001823     Document Type: Article

References (43)

1. Dye C, et al. Consensus Statement. Global burden of turberculosis: estimated incidence, prevalence and mortality by country. Journal of the American Medical Association 1999; 282: 677-686.
2. Ferebee SH, et al. Controlled trial of Isoniazid prophylaxis in mental institutions. American Journal of Respiratory Diseases 1963; 88: 161-175.
3. Ehlers S. Lazy, dynamic or minimally recrudescent? On the elusive nature and location of the mycobacterium responsible for latent tuberculosis. Infection 2009; 37: 87-95.
4. Cooper AM, Khader SA. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunology Reviews 2008; 226: 191-204.
5. Hussain R, et al. Longitudinal tracking of cytokines after acute exposure to tuberculosis: association of distinct cytokine patterns with protection and disease development. Clinical Vaccine Immunology 2007; 14: 1578-1586.
6. Demissie A, et al. The 6-kilodalton early secreted anti-genic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of inter-leukin-4 and reduced levels of gamma interferon. Infection & Immunity 2006; 74: 2817-2822.
7. Torrado E, Cooper AM. IL-17 and Th17 cells in tuberculosis. Cytokine Growth Factor Reviews 2010; 21: 455-462.
8. Tsegaye A, et al. Immunophenotyping of blood lymphocytes at birth, during childhood, and during adulthood in HIV-1-uninfected Ethiopians. Clinical Immunology 2003; 109: 338-346.
9. Black GF, et al. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 2002; 359: 1393-1401.
10. Lalor MK, et al. BCG vaccination induces different cy-tokine profiles following infant BCG vaccination in the UK and Malawi. Journal of Infectious Diseases 2011; 204: 1075-1085.
11. Rook GA, Dheda K, Zumla A. Immune systems in developed and developing countries; implications for the design of vaccines that will work where BCG does not. Tuberculosis (Edinburgh) 2006; 86: 152-162.
12. Esmail H, Barry 3rd CE, Wilkinson RJ. Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies. Drug Discovery Today 2012; 17: 514-521.
13. Rook GA, Dheda K, Zumla A. Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting? Vaccine 2005; 23: 2115-2120.
14. Perry S, Hussain R, Parsonnet J. The impact of mucosal infections on acquisition and progression of tuberculosis. Mucosal Immunology 2011; 4: 246-251.
15. Perry S, de Martel C, Parsonnet J. Helicobacter pylori. In: Brachman PS, Brutyn EA, eds. Bacterial Infections of Humans, 4th edn. New York: Springer, 2009.
16. D'Elios MM, et al. Helicobacter pylori, T cells and cytokines: the 'dangerous liaisons'. FEMS Immunology & Medical Microbiology 2005; 44: 113-119.
17. Perry S, et al. Infection with Helicobacter pylori is associated with protection against tuberculosis. PLoS One 2010; 5: 1-9.e8804.
18. Hotez PJ, et al. Helminth infections: the great neglected tropical diseases. Journal of Clinical Investigation 2008; 118: 1311-1321.
19. Maizels RM, Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nature Reviews Immunology 2003; 3: 733-744.
20. Cooper PJ, et al. Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR. Infection & Immunity 2001; 69: 1574-1580.
21. Kassu A, et al. Role of incidental and/or cured intestinal parasitic infections on profile of CD4+ and CD8+ T cell subsets and activation status in HIV-1 infected and uninfected adult Ethiopians. Clinical & Experimental Immunology 2003; 132: 113-119.
22. Elias D, et al. Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production. Vaccine 2008; 26: 3897-3902.
23. Fox JG, et al. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nature Medicine 2000; 6: 536-542.
24. Erdman SE, et al. Unifying roles for regulatory T cells and inflammation in cancer. International Journal of Cancer 2010; 126: 1651-1665.
25. Lundgren A, et al. Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infection & Immunity 2003; 71: 1755-1762.
26. Allen JE, Maizels RM. Diversity and dialogue in immunity to helminths. Nature Reviews Immunology 2011; 11: 375-388.
27. Maizels RM. Infections and allergy-helminths, hygiene and host immune regulation. Current Opinions in Immunology 2005; 17: 656-661.
28. Blaser MJ, Chen Y, Reibman J. Does Helicobacter pylori protect against asthma and allergy? Gut 2008; 57: 561-567.
29. Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nature Reviews Immunology 2001; 1: 69-75.
30. Ricks P, et al. Estimating the burden of tuberculosis among foreign born persons acquired prior to entering the U.S., 2005-2009. PLoS One 2011; 6: 1-6.
31. Perry S, et al. Reproducibility of QuantiFERON-TB gold in-tube assay. Clinical Vaccine Immunology 2008; 15: 425-432.
32. Replogle ML, et al. Biologic sex as a risk factor for Helicobacter pylori infection in healthy young adults. American Journal of Epidemiology 1995; 142: 856-863.
33. de Martel C, et al. Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. Journal of Infectious Diseases 2005; 191: 761-767.
34. Affifi AA, Clark V. Principal components analysis. In: Computer Aided Multivariate Analysis. New York: Chapman & Hall, 1990, pp. 371-393.
35. Agresti A. An Introduction to Categorical Data Analysis, 2nd edn. Hoboken, New Jersey: John Wiley & Sons, 2007.
36. Elias D, Akuffo H, Britton S. Helminths could influence the outcome of vaccines against TB in the tropics. Parasite Immunology 2006; 28: 507-513.
37. Lalor MK, et al. Population differences in immune responses to Bacille Calmette-Guerin vaccination in infancy. Journal of Infectious Diseases 2009; 199: 795-800.
38. Lin PL, Flynn JL. Understanding latent tuberculosis: a moving target. Journal of Immunology 2010; 185: 15-22.
39. Black GF, et al. Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults. Clinical Diagnostic Laboratory Immunology 2003; 10: 602-611.
40. Garg PK, et al. Risk of intestinal helminth and protozoan infection in a refugee population. American Journal of Tropical Medicine and Hygiene 2005; 73: 386-391.
41. Centers for Disease Control and Prevention. Overseas refugee guidelines: intestinal parasites (http://www.cdc.gov/immigrantrefugeehealth/pdf/intestinal- parasites-domestic.pdf). Accessed 16 April 2012.
42. Herrera V, et al. Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clinical Infectious Diseases 2011; 52: 1031-1037.
43. Cerf-Bensussan N, Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes? Nature Reviews Immunology 2010; 10: 735-744.